CAS: 130018-77-8; (R)-Cetirizine

该化合物是第三代抗脊髓灰质炎和活性抗脊髓灰质炎的抗脊髓灰质炎,对外围H1受体表现出强大和选择性的对抗,其主要优势在于其效力的提高和镇静效应的减少,而与种族的丙基里兹因对H1受体的亲近性较高而导致的镇静效应的减少. 利沃切蒂里兹因表现出行动迅速和持续时间的延长,使得它适合管理性过敏条件,如鼻炎和慢性泌尿炎. 其低代谢物含量和最低程度的药物-药物互动进一步凸显了其有利的药用植物基因特征. 化合物的高生物利用率和有限的...

结构式图片

上下游产品

西替利嗪 Cetirizine 83881-51-0
(R)-(2-{4-[(4-Chlorophenyl)Phenylmethyl]Piperazin-1-Yl}Ethoxy)Acetic Acid Methyl Ester
左氯替西汀酰胺杂质盐酸盐 (R)-2-(2-{4-[(4-Chlorophenyl)Phenylmethyl]Piperazin-1-Yl}Ethoxy)Acetamide 909779-33-5
(+)-[2-[4-[(4-氯苯基)-苯基甲基]-1-哌嗪基]]乙醇 (+)-[2-[4-[(4-Chlorophenyl)-Phenyl Methyl]-1-Piperazinyl]]Ethanol 705289-61-8
2-[4-[(4-氯苯基)苯基甲基]哌嗪-1-基]乙醇 2-{4-[(4-Chlorophenyl)(Phenyl)Methyl]Piperazin-1-Yl}Ethan-1-Ol 109806-71-5
R-2-(2-(4-((4-Chlorophenyl)(Phenyl)Methyl)Piperazin-1-yl)-2-Oxoethoxy)Acetic Acid 1058165-14-2
左西替利嗪n-苄基酰胺 Levocetirizine N-Benzyl Amide 1150310-68-1
R-Methyl 2-(2-(4-((4-Chlorophenyl)(Phenyl)Methyl)Piperazin-1-yl)-2-Oxoethoxy)Acetate 1201648-47-6 R-2-(2-(4-((4-Chlorophenyl)(Phenyl)Methyl)Piperazin-1-yl)-2-Oxoethoxy)Acetyl Chloride (R)-1-((4-Chlorophenyl)(Phenyl)Methyl)Piperazine 300543-56-0

合成工艺路线路线简述

    左氯替西汀酰胺杂质盐酸盐置于盐酸体系中,用 水 用作溶剂,化学反应 4.0H,反应生成左西替利嗪
    参考文献:Process For Preparing (S) And (R)-2-[4-(4-Chlorobenzhydryl)Piperazin-1-Yl]-Ethoxyacetamide
    标题:Process For Preparing (S) And (R)-2-[4-(4-Chlorobenzhydryl)Piperazin-1-Yl]-Ethoxyacetamide
    摘要:本发明涉及一种通过使用多柱色谱分离外消旋混合物来制备(S)-2-[4-(4-氯苯基)-1-哌嗪基]-乙氧基乙酰胺和(R)-2-[4-(4-氯苯基)-1-哌嗪基]-乙氧基乙酰胺的方法.

    海关参考信息

    专利信息


    专利号:US-8350031-B2
    优先权日:2008-06-02
    标 题:Processes for the synthesis of levocetirizine and intermediates for use therein
    发明人:RAO DHARMARAJ RAMACHANDRA; KANKAN RAJENDRA NARAYANRAO; GHAGARE MARUTI; CHIKHALIKAR SANDIP VASANT
    权利人:CIPLA LTD; RAO DHARMARAJ RAMACHANDRA; KANKAN RAJENDRA NARAYANRAO; GHAGARE MARUTI; CHIKHALIKAR SANDIP VASANT
    摘要:The present invention provides a compound of formula (IV) n nwherein R is Cl, Br, NO 2 , OH or OR′, and R′ is alkyl, and its use in the synthesis of levocetirizine, including its use in the synthesis of (−)-1-[(4-chlorophenyl)-phenylmethyl]piperazine, an intermediate useful in the synthesis of levocetirizine. The present invention also provides compounds (II) and (III) which are useful in the synthesis of compound (IV).

    专利号:US-7619085-B2
    优先权日:2005-03-03
    标 题 :Pyroglutamate salts and their use in the optical resolution of intermediates for the synthesis of dextrocetirizine and levocetirizine
    发明人:PALACIO MAGALI; ATES CELAL
    权利人:UCB PHARMA SA
    摘要:The present invention relates to (S)-2-[4-(4-chlorobenzhydryl)piperazin-1-yl]-ethoxyacetamide-(S)-pyrrolidone-5-carboxylic acid salt; (R)-2-[4-(4-chlorobenzhydryl)piperazin-1-yl]-ethoxyacetamide-(S)-pyrrolidone-5-carboxylic acid salt; (S)-2-[4-(4-chlorobenzhydryl)piperazin-1-yl]-ethoxyacetamide-(R)-pyrrolidone-5-carboxylicacid salt; or (R)-2-[4-(4-chlorobenzhydryl)piperazin-1-yl]-ethoxycetamide-(R)-pyrrolidone-5-carboxylic salt. The present invention relates also to a process for preparing (S)-2-[4-(4-chlorobenzhydryl)piperazin-1-yl]-ethoxyacetamide (I) and (R)-2-[4-(4-chlorobenzhydryl) piperazin-1-yl]-ethoxyacetamide (II) by chemical resolution of a mixture. These compounds are respectively intermediates for the synthesis of dextrocetirizine and levocetirizine.

    专利号:US-7807837-B2
    优先权日:2004-05-07
    标 题 :Scalable synthesis of imidazole derivatives
    发明人:JONES TODD K; MANI NEELAKANDHA
    权利人:JANSSEN PHARMACEUTICA NV
    摘要:Imidazole derivatives, compositions containing them, methods of preparing them, including regioselective scale-up synthetic methods, and methods of using them.

    专利号:EP-1354593-B1
    优先权日:2002-04-08
    标题 :use of an extract of a non-photosynthetic filamentous bacterium as an agent for enhancing the endogenous synthesis of superoxide dismutase
    发明人:MAHE YANN; MEYBECK ALAIN
    权利人:OREAL
    摘要:Promoting endogenous production of superoxide dismutase (SOD) comprises the use of an extract (I) of non-photosynthetic, non-fruiting filamentous bacteria in cosmetic, dermatological or pharmaceutical applications. Use of an extract (I) of non-photosynthetic, non-fruiting filamentous bacteria: (1) in a composition based on a cosmetic medium, as an agent for promoting endogenous production of superoxide dismutase (SOD); or (2) for production of a pharmaceutical or dermatological composition for promoting endogenous production of SOD. Independent claim are also included for: (1) a composition comprising a physiological medium containing Vitreoscilla filliformis extract (Ia) and lycopene (specifically at 0.000000001-0.1 wt. %) or a compound having catalase activity and/or a compound having peroxidase activity; and (2) cosmetic treatment methods for treating loss of firmness and/or elasticity of the skin or for treating skin exposed to sunlight, involving application of compositions containing (Ia).

    专利号:US-2006111369-A1
    优先权日:2004-11-10
    标 题:Synthesis, characterization and biological action of optically active isomers of floxacins
    发明人:SOMBERG JOHN C; RANADE VASANT V
    权利人:SOMBERG JOHN C; RANADE VASANT V
    摘要:Disclosed herein is the method for synthesis and separation of enantiospecific isomers of floxacins. These isomers can be used to study the antibacterial action, as well as cardiac effects, such as arrhythmogenic activity, QT internal prolongation and dispersion, and Ikr inhibition in humans. A method for the identification of chiral isolates of the floxacins that are devoid or possess less QT prolonging action and thus cause less arthropathy especially of the Torsades de pointes variety. Also disclosed are methods for assaying these isomeric compounds present in the biological fluids.

    专利号:US-7381821-B2
    优先权日:2003-01-23
    标 题 :Piperazine derivatives and their use as synthesis intermediates
    发明人:ATES CELAL; CAVOY EMILE; BOUVY DIDIER
    权利人:UCB SA
    摘要:The present invention relates to new enantiomerically pure piperazine derivatives of formula (I) wherein Y represents hydroxy or a leaving group and n is 1, 2, 3, 4 or 5, and to their use as synthesis intermediates, especially for the preparation of pharmaceutically active compounds
    北京嘉瑞时代科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.jarytimes.com
    电话: 010-58236920 13426038769👤
    📞北京嘉瑞时代科技有限公司 ⚠️参考联系方式

    销售电话:010-58236920 13426038769
    邮箱:askmryu@126.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    北京世纪迈劲生物科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.mediking.cn
    电话:010-81769521👤
    📞 北京世纪迈劲生物科技有限公司⚠️参考联系方式

    电话: 010-81769521
    邮件:sales@mediking.cn
    网址: http://www.mediking.cn
    地址:北京市亦庄经济技术开发区永昌中路甲6号院A座4层
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    北京市亦庄经济技术开发区永昌中路甲6号院A座4层
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别. 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Weinberger M, Hendeles L. Nonprescription medications for respiratory symptoms: Facts and marketing fictions. Allergy Asthma Proc. 2018 May 1;39(3):169-176. doi: 10.2500/aap.2018.39.4117. doi: 10.1002/hup.2655. Epub 2018 Mar 13.
    3: Domagała A, Szepietowski J, Reich A. Antihistamines in the treatment of pruritus in psoriasis. Postepy Dermatol Alergol. 2017 Oct;34(5):457-463. doi: 10.5114/ada.2017.71112. Epub 2017 Oct 31.
    4: Okubo K, Uchida E, Terahara T, Akiyama K, Kobayashi S, Tanaka Y. Efficacy and safety of emedastine patch, a novel transdermal drug delivery system for allergic rhinitis: Phase III, multicenter, randomized, double-blinded, placebo-controlled, parallel-group comparative study in patients with seasonal allergic rhinitis. Allergol Int. 2018 Jan 29. pii: S1323-8930(17)30189-2. doi: 10.1016/j.alit.2017.12.005. [Epub ahead of print] doi: 10.4103/ijdvl.IJDVL_860_17. doi: 10.4103/ijd.IJD_710_16.

    合成参考文献


    参考文献:10.1159/000089035
    摘要:Pitarch G, Torrijos A, Martínez-Menchón T, Sánchez-Carazo JL, Fortea JM. Familial aquagenic urticaria and bernard-soulier syndrome. Dermatology. 2006;212(1):96–7. doi: 10.1159/000089035.
    参考文献:10.1007/s00213-011-2400-7
    摘要:Verster JC, Roth T. Drivers can poorly predict their own driving impairment: a comparison between measurements of subjective and objective driving quality. Psychopharmacology (Berl). 2012 Feb;219(3):775–81.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知